Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis-Reference-Cited by-同舟云学术

Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Published:2015-01-20 Issue:3 Volume:313 Page:275
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Burt Richard K.¹,Balabanov Roumen²,Han Xiaoqiang¹,Sharrack Basil³,Morgan Amy¹,Quigley Kathleeen¹,Yaung Kim¹,Helenowski Irene B.⁴,Jovanovic Borko⁴,Spahovic Dzemila¹,Arnautovic Indira¹,Lee Daniel C.⁵,Benefield Brandon C.⁶,Futterer Stephen⁷,Oliveira Maria Carolina⁸,Burman Joachim⁹

Affiliation:

1. Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

2. Department of Neurology, Rush University Medical Center, Chicago, Illinois

3. Academic Department of Neuroscience, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, England

4. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

5. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

6. Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois

7. Department of Neuro-Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

8. Division of Clinical Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil

9. Department of Neuroscience and Neurology, Uppsala University, Uppsala, Sweden

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis;Bone Marrow Transplantation;2024-08-26

2. Neuropsychological outcomes following HSCT in MS: A systematic review;Multiple Sclerosis and Related Disorders;2024-08

3. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?;Current Neuropharmacology;2024-07

4. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis;Neurologic Clinics;2024-02

5. Ongoing randomized clinical trials on HSCT in multiple sclerosis;Handbook of Clinical Neurology;2024